News
Click claims FDA okay for first-in-class schizophrenia DTx
Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
News
UK backs all health AI proposals in commission report
The UK will accept all 44 proposals made in a recent report on using AI tools in the NHS, including continuous monitoring after deployment.
Digital
Sponsored
Solution Spotlight: Axtria HIQ
Axtria HIQ is an agentic analytics product built specifically for pharmaceutical headquarters teams.
News
Everlywell rolls out Clairity AI for breast cancer in US
Digital health firm Everlywell is rolling out a Clairity AI, which can assess the risk of developing breast cancer from a mammogram, across the US.
News
UK puts £80m behind dementia diagnosis push
The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
Debates
News
Press Releases
Editor's Picks
Editor's Picks
